SCHEMBL5672787

SCHEMBL5672787

Cc1ccc(-n2[nH]c(-c3ccccc3)cc2=O)cc1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 4/20 0.58
▸ MEN1 O00255 7/20 0.58
▸ KMT2A Q03164 7/20 0.58
▸ MAPT P10636 6/20 0.58
▸ LMNA P02545 4/20 0.58
▸ HTT P42858 4/20 0.58
▸ RAB9A P51151 2/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ CYP2C9 P11712 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ GAA P10253 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ NOX4 Q9NPH5 1/20 0.51
▸ NOX1 Q9Y5S8 1/20 0.51
▸ KDM4E B2RXH2 4/20 0.47
▸ TDP1 Q9NUW8 3/20 0.47
▸ TP53 P04637 2/20 0.47
▸ POLB P06746 2/20 0.47
▸ ALOX15 P16050 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11755279 0.84 MAPT (0.65) ALKBH5MEN1KMT2AMAPTLMNA
SCHEMBL2085581 0.82 MAPT (0.69) MEN1KMT2AMAPTLMNAHTT
SCHEMBL5673458 0.82 ALKBH5 (0.61) ALKBH5MEN1KMT2AMAPTLMNA
SCHEMBL23400261 0.78 NOX4 (0.54) MEN1KMT2AMAPTLMNAHTT
SCHEMBL1414675 0.78 MAPT (0.65) MEN1KMT2AMAPTLMNAHTT
SCHEMBL23400761 0.78 MAPT (0.57) ALKBH5MEN1KMT2AMAPTLMNA
SCHEMBL407942 0.77 ALKBH5 (0.64) ALKBH5MEN1KMT2AMAPTLMNA
SCHEMBL9808001 0.77 MEN1 (0.56) MEN1KMT2AMAPTLMNAHTT
SCHEMBL11756851 0.76 KMT2A (0.55) ALKBH5MEN1KMT2AMAPTLMNA
SCHEMBL23398682 0.76 MAPT (0.55) ALKBH5MEN1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213965-B1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2006-01-18 — — EP disclosed
US-6670387-B1 Thrombocytopenia; hydroxy-1-azo-naphthalene derivatives; 3-hydroxy-4-((2-hydroxy-1-naphthalenyl)azo-)-1-naphthalenesul fonic acid; promoters of thrombopoiesis and megakaryocytopoi esis; enhancing platelet production; agonizing TPO receptor SMITHKLINE BEECHAM CORPORATION 2003-12-30 — — US disclosed
US-6642265-B1 Treating thrombocytopenia, in a mammal, including a human, by administering a hydroxy-1-azobenzene derivative SMITHKLINE BEECHAM CORPORATION 2003-11-04 — — US disclosed
EP-1213965-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2003-05-02 — — EP disclosed
EP-1156804-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2002-08-07 — — EP disclosed
EP-1213965-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2002-06-19 — — EP disclosed
EP-1156804-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-28 — — EP disclosed
WO-2001017349-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BECKMAN CORPORATION (US) 2001-03-15 — — WO disclosed
WO-2000035446-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2000-06-22 — — WO disclosed
Send feedback